Inclusion of BLIMP-1( ) effector regulatory T cells improves the Immunoscore in a cohort of New Zealand colorectal cancer patients: a pilot study
Kirsten A Ward-Hartstonge, John L McCall, Timothy R McCulloch, Ann-Kristin Kamps, Adam Girardin, Erika Cretney, Fran M Munro, Roslyn A Kemp
Cancer Immunology, Immunotherapy | SPRINGER | Published : 2017
This study was funded by the Genesis Oncology Trust and Lotteries Health New Zealand. Kirsten Ward-Hartstonge was supported by the Todd Foundation for Excellence, a Brenda Shore Award for Women and a PhD scholarship from Lotteries Health New Zealand. Erika Cretney was supported by a National Health and Medical Research Council (NHMRC) Fellowship and project grant #1047313. This work was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIIS. Adam Girardin received travel support for techniques from the Maurice and Phyllis Paykel Trust.